So many women on this site have described waking up exhausted every single day and being told their bloodwork looks fine. Some were handed antidepressants. Some were told to lose weight. A surprising number of them eventually got a sleep study and came back with a sleep apnea diagnosis they never expected. This one deserves to be on every woman's radar going into perimenopause.
Learn more about Rose →Progesterone directly stimulates the respiratory centers in the brainstem, increasing the drive to breathe and helping to maintain consistent ventilation during sleep. When progesterone levels fall in perimenopause and menopause, that protective stimulus disappears, making breathing during sleep less regulated and more vulnerable to collapse. This is one of the most well-documented hormonal mechanisms behind the spike in sleep apnea risk in postmenopausal women.
Estrogen receptors are present in the muscles that line the upper airway, including the genioglossus — the tongue muscle whose relaxation is the primary mechanical cause of obstructive sleep apnea. When estrogen declines, those muscles lose some of their responsiveness and tone, making the airway more prone to partial or complete collapse during sleep. This structural change happens independently of weight gain, which means even lean women are affected.
The classic sleep apnea presentation — loud snoring, witnessed breathing pauses, gasping, and excessive daytime sleepiness — is predominantly a male pattern. Women with sleep apnea are more likely to report insomnia, morning headaches, fatigue, mood disturbances, anxiety, and unrefreshing sleep, all of which overlap heavily with general perimenopause symptoms and with depression. Because these symptoms don't trigger the same clinical suspicion, women are significantly less likely to be referred for a sleep study.
Many screening questionnaires for sleep apnea, including the widely used STOP-BANG tool, weight heavily toward snoring as a primary indicator. Women with sleep apnea snore less loudly and less consistently than men, partly because of anatomical differences in airway structure and partly because women tend to experience more hypopneas — shallow breathing events — rather than full apneas. A woman who answers no to the snoring question may never be referred for testing, even if she is waking up dozens of times a night.
While men with sleep apnea classically fall asleep at the wheel or during meetings, women are more likely to report difficulty staying asleep and waking repeatedly through the night, which clinically resembles primary insomnia rather than a breathing disorder. This symptomatic difference means women are frequently treated with sleep hygiene advice, CBT-I, or sedative medications rather than having the underlying airway problem investigated. Treating insomnia without addressing sleep apnea provides only partial relief at best.
Hot flashes and night sweats cause their own arousals from sleep, and because these are universally recognized as menopause symptoms, both women and clinicians often attribute all nighttime disruption to vasomotor activity. Research has shown, however, that sleep apnea and hot flashes can coexist and that the arousal response from an apneic event can itself trigger a hot flash, creating a cycle that is nearly impossible to untangle without objective sleep testing. Assuming that all nighttime waking is hormonal can delay a sleep apnea diagnosis by years.
The hormonal shift at menopause promotes a redistribution of body fat from the hips and thighs toward the abdomen and neck — even in women whose overall weight does not change significantly. Increased neck circumference is one of the strongest anatomical predictors of obstructive sleep apnea because fat deposits around the throat narrow the airway and increase its collapsibility during sleep. This means the menopause transition can increase sleep apnea risk through both hormonal and mechanical pathways simultaneously.
Several large studies have found that untreated sleep apnea confers a disproportionately higher cardiovascular risk in women compared to men, including elevated rates of hypertension, atrial fibrillation, and stroke. Postmenopausal women are already in a period of increased cardiovascular vulnerability as the protective effects of estrogen on the vascular system wane, meaning untreated sleep apnea compounds a risk that is already rising. This makes missing the diagnosis in women not just frustrating but genuinely consequential for long-term health.
Studies on menopausal hormone therapy show that women using combined estrogen and progesterone therapy have lower rates of sleep apnea than untreated postmenopausal women, which is consistent with the known respiratory and airway-protective roles of both hormones. This suggests that MHT may help reduce risk or moderate severity as part of a broader picture, but it has not been studied or approved as a standalone treatment for diagnosed obstructive sleep apnea. Women who already have significant sleep apnea still need direct airway treatment — typically CPAP or a mandibular advancement device — alongside any hormonal management.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.